Search

everythinglearnresearchcommunity

for

Search:↓

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Baldness score can't be used to predict prostate size.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

TSH is usually the only test needed to check thyroid function in primary care.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

Dermatologists can help detect and manage eating disorders by recognizing skin changes.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Auto-portraits help evaluate scalp hair.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Most adult females with acne do not have hormonal imbalances, but some show signs of excess male hormones.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.